ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OLIVER DIAZ M.D.

Cardiovascular Disease

17,767

$973K

471
377 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 30%

$55
Average prescription price

Avg: $75

MICHAEL SHARON MD

Cardiovascular Disease

12,116

$879K

626
595 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 30%

$73
Average prescription price

Avg: $75

ANTHONY D'SOUZA M.D.

Cardiovascular Disease

10,812

$945K

984
911 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 30%

$87
Average prescription price

Avg: $75

ROBERT JARRETT MD

Cardiovascular Disease

10,143

$883K

567
466 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 30%

$87
Average prescription price

Avg: $75

PARVEEN KHANNA MD

Cardiovascular Disease

9,006

$953K

911
771 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 30%

$106
Average prescription price

Avg: $75

HAZAR DAHHAN M.D.

Cardiovascular Disease

8,565

$767K

889
813 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 30%

$90
Average prescription price

Avg: $75

MURUGESAPILLAI KONESWARAN MD

Cardiovascular Disease

8,389

$465K

235
202 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 30%

$55
Average prescription price

Avg: $75

STEVEN KUNKES M.D.

Cardiovascular Disease

8,337

$570K

696
657 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 30%

$68
Average prescription price

Avg: $75

JOHN BARON MD

Cardiovascular Disease

8,064

$438K

547
508 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 30%

$54
Average prescription price

Avg: $75

ROBERT BORKOWSKI MD

Cardiovascular Disease

8,060

$795K

1050
938 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 30%

$99
Average prescription price

Avg: $75

DAVID HENRY M.D.

Cardiovascular Disease

8,023

$510K

440
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 30%

$64
Average prescription price

Avg: $75

JOHN CHANDLER

Cardiovascular Disease

7,170

$605K

610
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 30%

$84
Average prescription price

Avg: $75

EDWARD TUOHY M.D.

Cardiovascular Disease

6,448

$461K

540
486 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 30%

$72
Average prescription price

Avg: $75

JOSEPH CORNING MD

Cardiovascular Disease

6,431

$573K

589
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 30%

$89
Average prescription price

Avg: $75

KESHAVA AITHAL MD

Cardiovascular Disease

6,363

$494K

513
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 30%

$78
Average prescription price

Avg: $75

ANTHONY LASALA M.D.

Cardiovascular Disease

6,276

$490K

603
573 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 30%

$78
Average prescription price

Avg: $75

DAVID GALLO MD

Cardiovascular Disease

6,233

$481K

622
567 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 30%

$77
Average prescription price

Avg: $75

STEVEN JACOBY M.D., F.A.C.C.

Cardiovascular Disease

6,139

$457K

472
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 30%

$74
Average prescription price

Avg: $75

STEVEN HOROWITZ M.D.

Cardiovascular Disease

6,095

$493K

563
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 30%

$81
Average prescription price

Avg: $75

KATHLEEN HARPER D.O.

Cardiovascular Disease

5,986

$281K

446
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 30%

$47
Average prescription price

Avg: $75

JAMES CARDON M.D.

Cardiovascular Disease

5,978

$536K

558
515 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 30%

$90
Average prescription price

Avg: $75

SHIBA JHAWAR MD

Cardiovascular Disease

5,890

$441K

364
340 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 30%

$75
Average prescription price

Avg: $75

CHANDRA SACHETI M.D

Cardiovascular Disease

5,846

$268K

479
434 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 30%

$46
Average prescription price

Avg: $75

ROBERT KAHAN MD

Cardiovascular Disease

5,846

$414K

547
493 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 30%

$71
Average prescription price

Avg: $75

ROBERT MOSKOWITZ M.D.

Cardiovascular Disease

5,790

$346K

515
470 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 30%

$60
Average prescription price

Avg: $75

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank